banner2

Getting started
Fischer’s Aldehyde

Fischer’s Aldehyde - China Factory, Suppliers, Manufacturers

Fischer’s Aldehyde, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Fischer's Aldehyde CAS 84-83-3 — Fischer's Aldehyde CAS 84-83-3 Purity >99.0% (HPLC) Factory High Quality
Read More

Phenylacetaldehyde CAS 122-78-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com www.ruifuchem.com — Phenylacetaldehyde CAS 122-78-1 Purity >95.0% (GC) Contains 0.01% Citric Acid as Stabilizer

3-[(Benzyloxycarbonyl)amino]propionaldehyde CAS 65564-05-8 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3-[(Benzyloxycarbonyl)amino]propionaldehyde CAS 65564-05-8 Purity >98.0% (HPLC)

3,5-Dibromosalicylaldehyde CAS 90-59-5 Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3,5-Dibromosalicylaldehyde CAS 90-59-5 Purity >98.0% (HPLC)

Valeraldehyde CAS 110-62-3 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Valeraldehyde (Pentanal) CAS 110-62-3 Purity ≥98.0% (GC)

Diphenylacetaldehyde CAS 947-91-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Diphenylacetaldehyde CAS 947-91-1 Purity >95.0% (GC)

Veratraldehyde CAS 120-14-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Veratraldehyde CAS 120-14-9 3,4-Dimethoxybenzaldehyde Purity >99.0% (GC) Factory

banner4

Top Selling Products

Related Blog
Reviews

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...

2022.06.29 08:11:20
2022.06.23 11:22:33
2022.03.01 13:30:41
2022.02.27 09:58:56
2021.12.03 02:33:11
2021.10.29 06:13:02

related search